| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.6M | +10.7% |
| Cost of Revenue | $4.8M | +11.4% |
| Gross Profit | $6.8M | +10.2% |
| R&D Expense | $8.1M | +76.7% |
| SG&A Expense | $5.1M | +108.5% |
| Operating Income | -$11.1M | -203.1% |
| Income Tax | $0 | — |
| Net Income | -$12.0M | -323.9% |
| EPS (Basic) | -$0.36 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.1M | -32.5% |
| Inventory | $1.7M | +16.3% |
| Current Assets | $7.8M | -19.0% |
| Total Assets | $16.7M | +56.7% |
| Current Liabilities | $6.6M | +407.2% |
| Total Liabilities | $14.3M | +732.4% |
| Stockholders' Equity | $2.4M | -73.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.2M | -91.9% |
| Capital Expenditures | $550K | +39.8% |
| Investing Cash Flow | -$550K | -39.8% |
| Financing Cash Flow | $8.8M | -12.6% |
| Free Cash Flow | -$9.8M | -88.0% |
| -50.0% |